| Abbreviations | Meaning |
 | HTLF | Human T-cell Leukemia Virus Enhancer Factor |
 | TACE | Chlorotrianicene; Teichoic Acid Crude Extract; Transarterial Chemoembolization; Tumor-necrosis Factor Alpha Converting Enzyme |
 | T0 | No Evidence Of Primary Tumor [TNM (tumor-node-metastasis) Classification] |
 | SCLC | Small Cell Lung Cancer |
 | LL | Lymphocytic Lymphoma |
 | CAR | Cancer-associated Retinopathy |
 | RHUTNF | Recombinant Human Tumor-necrosis Factor |
 | T | Primary Tumor [TNM (tumor-node-metastasis) Classification: T0 No Evidence Of Primary Tumor, T1 To T4 Tumors In Progressing Sizes, And TX No Evidence Of Primary Tumor] |
 | AML | Acute Myeloblastic Leukemia |
 | HOS | Health Opinion Survey; High-order Spectrum; Holt-Oram Syndrome; Human Osteosarcoma; Hypoosmotic Swelling [test] |
 | CML | Chronic Myelocytic Leukemia |
 | CRC | Cancer Research Campaign |
 | CGAP | Cancer Genome Anatomy Project |
 | BCLL | B-cell Chronic Lymphocytic Leukemia |
 | GCTTS | Giant Cell Tumor Of Tendon Sheath |